The Effect of Aspalathin on Levels of Sugar and Lipids in Streptozotocin-Induced Diabetic and Normal Rats

Authors Information
Article Notes and Dates
To Cite : Najafian M, Najafian B, Najafian Z. The Effect of Aspalathin on Levels of Sugar and Lipids in Streptozotocin-Induced Diabetic and Normal Rats, Zahedan J Res Med Sci. 2016 ;18(11):e4963. doi: 10.17795/zjrms-4963.
Abstract
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Najafian M. A review of α-amylase inhibitors on weight loss and glycemic control in pathological state such as obesity and diabete. Comp Clin Pathol. 2014; 25(6): 1-12[DOI]
  • 2. Rosak C, Mertes G. Effects of acarbose on proinsulin and insulin secretion and their potential significance for the intermediary metabolism and cardiovascular system. Curr Diabetes Rev. 2009; 5(3): 157-64[PubMed]
  • 3. Najafian M. Curcumin as Inhibitor of Alpha Amylase to Control of Diabetes. Zahedan J Res Med Sci. 2014; : 29-34
  • 4. Til A, Nirmal S, Pattan S, Tambe V, Tare M. Antidiabetic effect of polyherbal combinations in STZ induced diabetes involve inhibition of α-amylase and α-glucosidase with amelioration of lipid profile. Phytopharmacol. 2012; 2(1): 46-57
  • 5. Saxena A, Vikram NK. Role of selected Indian plants in management of type 2 diabetes: a review. J Altern Complement Med. 2004; 10(2): 369-78[DOI][PubMed]
  • 6. Najafian M, Ebrahim-Habibi A, Yaghmaei P, Parivar K, Larijani B. Citral as a potential antihyperlipidemic medicine in diabetes: a study on streptozotocin-induced diabetic rats. Iran J Diabetes and Lipid Disord. 2011; 10: 1-8
  • 7. Najafian M, Jahromi MZ, Nowroznejhad MJ, Khajeaian P, Kargar MM. Phloridzin reduces blood glucose levels and improves lipids metabolism in streptozotocin-induced diabetic rats. Mol Biol Rep. 2011; 1(1): 1-8
  • 8. Russo GL. Ins and outs of dietary phytochemicals in cancer chemoprevention. Biochem Pharmacol. 2007; 74(4): 533-44[DOI][PubMed]
  • 9. Woods RK, Walters EH, Raven JM, Wolfe R, Ireland PD, Thien FC, et al. Food and nutrient intakes and asthma risk in young adults. Am J Clin Nutr. 2003; 78(3): 414-21[PubMed]
  • 10. Linseisen J, Rohrmann S, Miller AB, Bueno-de-Mesquita HB, Buchner FL, Vineis P, et al. Fruit and vegetable consumption and lung cancer risk: updated information from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer. 2007; 121(5): 1103-14[DOI][PubMed]
  • 11. Najafian M. Effect of Curcumin on Metabolism of Lipids in Streptozotocin Induced Diabetic and Normal Rats. Biomed Pharm J. 2014; 7(1): 383-91
  • 12. Ku SK, Kwak S, Kim Y, Bae JS. Aspalathin and Nothofagin from Rooibos (Aspalathus linearis) inhibits high glucose-induced inflammation in vitro and in vivo. Inflammation. 2015; 38(1): 445-55[DOI][PubMed]
  • 13. Kawano A, Nakamura H, Hata S, Minakawa M, Miura Y, Yagasaki K. Hypoglycemic effect of aspalathin, a rooibos tea component from Aspalathus linearis, in type 2 diabetic model db/db mice. Phytomedicine. 2009; 16(5): 437-43[DOI][PubMed]
  • 14. Kondo M, Hirano Y, Nishio M, Furuya Y, Nakamura H, Watanabe T. Xanthine oxidase inhibitory activity and hypouricemic effect of aspalathin from unfermented rooibos. J Food Sci. 2013; 78(12): 1935-9[DOI][PubMed]
  • 15. Khan AU, Gilani AH. Selective bronchodilatory effect of Rooibos tea (Aspalathus linearis) and its flavonoid, chrysoeriol. Eur J Nutr. 2006; 45(8): 463-9[DOI][PubMed]
  • 16. Bernfeld P. Alpha, and beta amylases. Methods Enzymol. 1955; 1: 149-51[DOI]
  • 17. Najafian M, Ebrahim-Habibi A, Hezareh N, Yaghmaei P, Parivar K, Larijani B. Trans-chalcone: a novel small molecule inhibitor of mammalian alpha-amylase. Mol Biol Rep. 2011; 38(3): 1617-20[DOI][PubMed]
  • 18. Najafian M, Ebrahim-Habibi A, Yaghmaei P, Parivar K, Larijani B. Core structure of flavonoids precursor as an antihyperglycemic and antihyperlipidemic agent: an in vivo study in rats. Acta Biochim Pol. 2010; 57(4): 553-60[PubMed]
  • 19. Najafian M, Amini S, Dehestani B, Parivar K, Ebrahim-Habibi A. Thioflavin T effect in diabetic Wistar rats: reporting the antihyperglycemic property of an amyloid probing dye. Pharmacol Rep. 2015; 67(2): 364-9[DOI][PubMed]
  • 20. Forouzanfar MH, Sepanlou SG, Shahraz S, Dicker D, Naghavi P, Pourmalek F, et al. Evaluating causes of death and morbidity in Iran, global burden of diseases, injuries, and risk factors study 2010. Arch Iran Med. 2014; 17(5): 304-20[PubMed]
  • 21. Skrha J. Diabetes mellitus--a global pandemic. Keynote lecture presented at the Wonca conference in Prague in June 2013. Eur J Gen Pract. 2014; 20(1): 65-8[DOI][PubMed]
  • 22. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011; 94(3): 311-21[DOI][PubMed]
  • 23. Huseini HF, Kianbakht S, Hajiaghaee R, Dabaghian FH. Anti-hyperglycemic and anti-hypercholesterolemic effects of Aloe vera leaf gel in hyperlipidemic type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial. Planta Med. 2012; 78(4): 311-6[DOI][PubMed]
  • 24. Machius M, Vertesy L, Huber R, Wiegand G. Carbohydrate and protein-based inhibitors of porcine pancreatic alpha-amylase: structure analysis and comparison of their binding characteristics. J Mol Biol. 1996; 260(3): 409-21[DOI][PubMed]
  • 25. de Beer D, Malherbe CJ, Beelders T, Willenburg EL, Brand DJ, Joubert E. Isolation of aspalathin and nothofagin from rooibos (Aspalathus linearis) using high-performance countercurrent chromatography: sample loading and compound stability considerations. J Chromatogr A. 2015; 1381: 29-36[DOI][PubMed]
  • 26. Iswaldi I, Arraez-Roman D, Rodriguez-Medina I, Beltran-Debon R, Joven J, Segura-Carretero A, et al. Identification of phenolic compounds in aqueous and ethanolic rooibos extracts (Aspalathus linearis) by HPLC-ESI-MS (TOF/IT). Anal Bioanal Chem. 2011; 400(10): 3643-54[DOI][PubMed]
  • 27. Dey B, Mitra A, Katakam P, Singla RK. Exploration of natural enzyme inhibitors with hypoglycemic potentials amongst Eucalyptus Spp. by in vitro assays. World J Diabetes. 2014; 5(2): 209-18[DOI][PubMed]
  • 28. DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am. 2004; 88(4): 787-835[DOI][PubMed]
  • 29. El-Abhar HS, Schaalan MF. Phytotherapy in diabetes: Review on potential mechanistic perspectives. World J Diabetes. 2014; 5(2): 176-97[DOI][PubMed]
  • 30. Lopez-Candales A. Metabolic syndrome X: a comprehensive review of the pathophysiology and recommended therapy. J Med. 2001; 32(5-6): 283-300[PubMed]
  • 31. Alberton EH, Damazio RG, Cazarolli LH, Chiaradia LD, Leal PC, Nunes RJ, et al. Influence of chalcone analogues on serum glucose levels in hyperglycemic rats. Chem Biol Interact. 2008; 171(3): 355-62[DOI][PubMed]
  • 32. Son MJ, Minakawa M, Miura Y, Yagasaki K. Aspalathin improves hyperglycemia and glucose intolerance in obese diabetic ob/ob mice. Eur J Nutr. 2013; 52(6): 1607-19[DOI][PubMed]
  • 33. Verges B. Lipid disorders in type 1 diabetes. Diabetes Metab. 2009; 35(5): 353-60[DOI][PubMed]
  • 34. Gosavi A, Flaker G, Gardner D. Lipid management reduces cardiovascular complications in individuals with diabetes and prediabetes. Prev Cardiol. 2006; 9(2): 102-7[PubMed]
  • 35. Peluso MR. Flavonoids attenuate cardiovascular disease, inhibit phosphodiesterase, and modulate lipid homeostasis in adipose tissue and liver. Exp Biol Med (Maywood). 2006; 231(8): 1287-99[PubMed]
  • 36. Marnewick JL, Rautenbach F, Venter I, Neethling H, Blackhurst DM, Wolmarans P, et al. Effects of rooibos (Aspalathus linearis) on oxidative stress and biochemical parameters in adults at risk for cardiovascular disease. J Ethnopharmacol. 2011; 133(1): 46-52[DOI][PubMed]
  • 37. Kim M, Kim Y. Hypocholesterolemic effects of curcumin via up-regulation of cholesterol 7a-hydroxylase in rats fed a high fat diet. Nutr Res Pract. 2010; 4(3): 191-5[DOI][PubMed]
  • 38. Peschel D, Koerting R, Nass N. Curcumin induces changes in expression of genes involved in cholesterol homeostasis. J Nutr Biochem. 2007; 18(2): 113-9[DOI][PubMed]
  • 39. Casaschi A, Maiyoh GK, Rubio BK, Li RW, Adeli K, Theriault AG. The chalcone xanthohumol inhibits triglyceride and apolipoprotein B secretion in HepG2 cells. J Nutr. 2004; 134(6): 1340-6[PubMed]
  • 40. Ogawa H, Ohno M, Baba K. Hypotensive and lipid regulatory actions of 4-hydroxyderricin, a chalcone from Angelica keiskei, in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 2005; 32(1-2): 19-23[DOI][PubMed]
  • 41. Jang EM, Choi MS, Jung UJ, Kim MJ, Kim HJ, Jeon SM, et al. Beneficial effects of curcumin on hyperlipidemia and insulin resistance in high-fat-fed hamsters. Metabolism. 2008; 57(11): 1576-83[DOI][PubMed]
  • 42. Asai A, Miyazawa T. Dietary curcuminoids prevent high-fat diet-induced lipid accumulation in rat liver and epididymal adipose tissue. J Nutr. 2001; 131(11): 2932-5[PubMed]
  • 43. Wang S, Chen B, Sun C. [Regulation effect of curcumin on blood lipids and antioxidation in hyperlipidemia rats]. Wei Sheng Yan Jiu. 2000; 29(4): 240-2[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Zahedan Journal of Research in Medical Sciences accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check